|
Previous: SCIENCE APPLICATIONS INTERNATIONAL CORP, SC 13D, EX-99.B, 2000-06-22 |
Next: CVB FINANCIAL CORP, 8-A12G, 2000-06-22 |
Washington, D.C. 20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 15, 2000
Pharmaceutical Formulations, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware |
|
0-11274 |
|
22-2367644 |
460 Plainfield Avenue, Edison, New Jersey 08818
(Address of Principal Executive Offices, including Zip Code)
Registrants telephone number, including area code: 732-985-7100
N.A.
(Former Name or Former Address, if Changed Since Last Report)
Item 5 Other Events
The Company did not make the June 15, 2000 interest payment due under its 8% Convertible Subordinated Debentures Due 2002. It is the Companys intention to make such payments within the 30 day period allowed before such nonpayment would become an event of default under the debenture indenture.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
PHARMACEUTICAL FORMULATIONS, INC. |
Dated: June 21, 2000
|